AcuNova

A pilot project with 27 patients suffering from dry age-related macular degeneration, were divided into three groups. The patients received intensive treatment over the course of four weeks. Each of the three groups were treated with a variation of AcuNova. As expected, the results varied between the three groups.

In test group No. 3, 60% of the patients experienced a 15,6% improvement in sight. In test group No. 2, 70% of the patients experienced a 28,5% improvement in sight, and finally in test group No. 1, 80% of the patients experienced an improvement of 15-40% in sight. The average rate of improvement in sight for all groups was 27%. Follow-up evaluations are scheduled after 6 months and a year.

MA48

A recent study by researchers at John Hopkins University on the efficacy of Micro Acupuncture 48 for eye diseases has generated many inquiries from the public across the world. Micro Acupuncture 48 is a contemporary acupuncture system that may help patients who face vision loss.

The best results that Dr Rosenfarb has seen clinically are for pain, peripheral neuropathies, and for eye diseases. The most commonly treated eye conditions that have seen good results include macular degeneration, glaucoma, diabetic retinopathy, Usher’s syndrome, optic nerve atrophy and retinitis pigmentosa

Alternative Eye Care

The AAO task force has acknowledged that acupuncture may be useful as an adjunctive therapy or as an acceptable alternative to conventional treatment. Journal Ophthalmology 2001